Linerixibat Long-term Safety and Tolerability Study
Condition: Cholestasis Intervention: Drug: Linerixibat Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials